ArticleMolecular and cellular biochemistry2026
circSH3GL3 inhibits glioma progression and invasion via regulating the PI3K/AKT and Wnt/β-catenin signaling pathways by competitively binding with miR-21-5p.
Article in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Circular RNAs (circRNAs) have been identified as vital regulators in a variety of cancers, including glioma.However, the role of circRNAs in glioma initiation and progression remains largely unclear. In this study, we investigated the expression profiles of circRNA in three paired samples of glioblastoma multiforme (GBM). Our findings revealed that circSH3GL3 is significantly downregulated in GBM tissues, and its downregulation is associated with the WHO grade and patient survival. Furthermore, our research demonstrated that elevated circSH3GL3 suppresses cell proliferation and invasion both in vitro and in vivo. Mechanistically, circSH3GL3 shares microRNA response elements with tissue inhibitor of metalloproteinase 3 (TIMP3) and smad family member 7 (SMAD7).The present study investigates the role of circSH3GL3 in glioma proliferation and invasion. It is demonstrated that circSH3GL3 competitively binds to miR-21-5p, thereby preventing the decrease in the levels of TIMP3 and SMAD7. These proteins subsequently regulate the PI3K/AKT and Wnt/β-catenin signaling pathways, respectively. These findings reveal the critical role of circSH3GL3 in inhibiting glioma proliferation and invasion via a ceRNA mechanism. The study concludes that circSH3GL3 is a valuable biomarker and therapeutic target for glioma patients.
Indexed as
Identifiers
41591628What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.